Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4977957 | 1.00 | USP2 (0.34) | USP2NPSR1 | |
| SCHEMBL4976696 | 1.00 | USP2 (0.34) | USP2NPSR1 | |
| SCHEMBL4976701 | 1.00 | USP2 (0.34) | USP2NPSR1 | |
| SCHEMBL4978147 | 1.00 | USP2 (0.34) | USP2NPSR1 | |
| SCHEMBL4976687 | 1.00 | USP2 (0.34) | USP2NPSR1 | |
| Alcohol SCHEMBL7795073 | 0.97 | USP2 (0.33) | USP2NPSR1 | |
| SCHEMBL112883 | 0.84 | USP2 (0.34) | USP2NPSR1 | |
| SCHEMBL713358 | 0.84 | USP2 (0.34) | USP2NPSR1 | |
| SCHEMBL4971485 | 0.84 | USP2 (0.34) | USP2NPSR1 | |
| SCHEMBL21219623 | 0.84 | USP2 (0.34) | USP2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0829463-B2 | Process for preparing an (E)-(R)-2-alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol | TAKASAGO PERFUMERY CO LTD (JP) | 2008-11-05 | — | — | EP | claimed |
| EP-0829463-B1 | (E)-(R)-2-Alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol, process for preparing the same, and use thereof in perfume compositions | TAKASAGO PERFUMERY CO LTD (JP) | 2001-12-19 | — | — | EP | claimed |
| US-6084138-A | CATALYST SELECTIVE AND STEREOSPECIFIC REDUCTION OF CORRESPONDING ALDEHYDE IN THE PRESENCE OF A RUTHENIUM-PHOSPHINE COMPLEX CATALYST, AN ALKALI OR ALKALINE EARTH METAL BASE AND AN AMINE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2000-07-04 | — | — | US | claimed |
| EP-0829463-A2 | (E)-(R)-2-Alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol, process for preparing the same, and use thereof in perfume compositions | Takasago International Corporation (JP) | 1998-03-18 | — | — | EP | claimed |
| JP-10147547-A | — | — | None | — | — | JP | disclosed |
| US-20230126581-A1 | Oxa-Sandalwood-Type Fragrance Compounds | SYMRISE AG (DE) | 2023-04-27 | — | — | US | disclosed |
| EP-4139270-A1 | OXA-SANDALWOOD-TYPE FRAGRANCE COMPOUNDS | Symrise AG (DE) | 2023-03-01 | — | — | EP | disclosed |
| WO-2021213627-A1 | OXA-SANDALWOOD-TYPE FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2021-10-28 | — | — | WO | disclosed |
| EP-0829463-B2 | Process for preparing an (E)-(R)-2-alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol | TAKASAGO PERFUMERY CO LTD (JP) | 2008-11-05 | — | — | EP | disclosed |
| EP-0829463-B2 | Process for preparing an (E)-(R)-2-alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol | TAKASAGO PERFUMERY CO LTD (JP) | 2008-11-05 | — | — | EP | disclosed |
| CN-1090601-C | (E) -(R) -2 -alkyl -4 -(2, 2, 3, -trimethylcyclopent -3 -en -1 -yl) 2 -buten -1 -ol, process for preparing same, and use thereof | TAKASAGO PERFUME IND CO LTD (JP) | 2002-09-11 | — | — | CN | disclosed |
| EP-0829463-B1 | (E)-(R)-2-Alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol, process for preparing the same, and use thereof in perfume compositions | TAKASAGO PERFUMERY CO LTD (JP) | 2001-12-19 | — | — | EP | disclosed |
| US-5994291-A | (E)-(R)-2-alkyl-4-(2,2,3,-Trimethylcyclopent-3-en-1-yl)-2-buten-1-ol, process for preparing the same, and use thereof | TAKASAGO INTERNATIONAL COPORATION (JP) | 1999-11-30 | — | — | US | disclosed |
| EP-0829463-A3 | (E)-(R)-2-Alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol, process for preparing the same, and use thereof in perfume compositions | Takasago International Corporation (JP) | 1999-06-02 | — | — | EP | disclosed |
| EP-0829463-A3 | (E)-(R)-2-Alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol, process for preparing the same, and use thereof in perfume compositions | Takasago International Corporation (JP) | 1999-06-02 | — | — | EP | disclosed |
| JP-H10147547-A | (E)-(R)-2-ALKYL-4-(2,2,3-TRIMETHYLCYCOPENT-3-ENE-1-YL)-2-BUTENE-1-OL DERIVATIVE, ITS PRODUCTION AND USE | TAKASAGO INTERNATL CORP | 1998-06-02 | — | — | JP | disclosed |
| CN-1179412-A | (E) -(R) -2 -alkyl -4 -(2, 2, 3, -trimethylcyclopent -3 -en -1 -yl) 2 -buten -1 -ol, process for preparing same, and use thereof | TAKASAGO PERFUMERY CO LTD (JP) | 1998-04-22 | — | — | CN | disclosed |
| EP-0829463-A2 | (E)-(R)-2-Alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol, process for preparing the same, and use thereof in perfume compositions | Takasago International Corporation (JP) | 1998-03-18 | — | — | EP | disclosed |
| EP-0829463-A2 | (E)-(R)-2-Alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol, process for preparing the same, and use thereof in perfume compositions | Takasago International Corporation (JP) | 1998-03-18 | — | — | EP | disclosed |
| EP-0829463-A2 | (E)-(R)-2-Alkyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)-2-buten-1-ol, process for preparing the same, and use thereof in perfume compositions | Takasago International Corporation (JP) | 1998-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230126581-A1 | Oxa-Sandalwood-Type Fragrance Compounds | FDFT1, FAAH2, ALDH1A1 | USP2 2991/4885NPSR1 1108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.